Sign in

CIK 0001877184 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

KESTRA MEDICAL TECHNOLOGIES, LTD.

Sign in to watch
Ticker
KMTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Apr 30
Incorporated
Bermuda
Entity type
operating
Phone
(425) 279-8002
Business address
3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND, WA, 98033
  1. 4 Planned sale See Remarks sold 15,000 shares at $20.27 ($304,124)
  2. 4 Grant or award Director acquired 8,300 shares (grant or award)
  3. 4 Planned sale See Remarks sold 15,000 shares at an average $25.60 ($384,020)
  4. 4 Planned sale See Remarks sold 15,000 shares at $22.80 ($342,024)
  5. 4 Planned sale See Remarks sold 10,500 shares at $26.69 ($280,201)
  6. 4 Planned sale See Remarks sold 15,000 shares at $26.59 ($398,847)
  7. 4 Grant or award Chief Business Officer acquired 19,557 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4/A Open-market buy Chief Commercial Officer bought 20,000 shares at $17.00 ($340,000)
  10. 4/A Open-market buy See Remarks bought 13,500 shares at $17.00 ($229,500)
  11. 4 Grant or award Director acquired 10,909 shares (grant or award)
  12. 4 Open-market buy Director bought 17,000 shares at $17.00 ($289,000)
  13. 4 Grant or award Director acquired 13,120 shares (grant or award)
  14. 4 Grant or award Director acquired 10,909 shares (grant or award)
  15. 4 Grant or award Director acquired 10,909 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 12,994 shares (grant or award)
  18. 4 Grant or award See Remarks acquired 88,235 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 22,059 shares (grant or award)
  20. 4 Grant or award See Remarks acquired 29,412 shares (grant or award)

Page 3 of 4 · 74 filings